| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/04/2009 | CN101357883A Antrodia camphoratea pimelie kelone compound for treating autoimmune disease and medicine composition |
| 02/04/2009 | CN101357223A Preparation method of anti-stress agent for fishing |
| 02/04/2009 | CN101357197A Naozhengzhu Duoyuanqu totipotence biological activity traditional Chinese medicine preparation |
| 02/04/2009 | CN101357196A Super high biomass omnipotent ordered high activity polymer biological activity traditional Chinese medicine preparation series |
| 02/04/2009 | CN101357175A Traditional Chinese medicine composition of foot soaking and massage |
| 02/04/2009 | CN101357145A New use of phenyl propanoid total glycoside |
| 02/04/2009 | CN101357130A Oral microparticles containing pseudoephedrine hydrochloride and cetirizine hydrochloride |
| 02/04/2009 | CN101357122A Use of carbon monoxide released substance in preparing medicine for treating pyemia |
| 02/04/2009 | CN100457911C Recombinant plasmid containing effective B cell activation factor gene promotor and its preparation method and uses |
| 02/04/2009 | CN100457901C Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 02/04/2009 | CN100457895C Mouse anti-human macrophage migration inhibiting factor monoclonal antibody and its application |
| 02/04/2009 | CN100457777C Leucine-based motif and clostridial neurotoxins |
| 02/04/2009 | CN100457767C Flavanone glycoside and its preparation and use |
| 02/04/2009 | CN100457753C N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/04/2009 | CN100457737C Quinolyl amide derivative and its preparation process and use |
| 02/04/2009 | CN100457180C Medicine composition for treating allergic disease and method for preparing the same |
| 02/04/2009 | CN100457179C Method and composition for oral vaccination |
| 02/04/2009 | CN100457119C Freeze dried ginseng polysaccharide powder for injection and its preparing process |
| 02/04/2009 | CN100457111C Pharmaceutical uses of staurosporine derivatives |
| 02/04/2009 | CN100457089C Solid liposome nanoparticles of arenobufagin and preparation method thereof |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/03/2009 | US7485730 Pharmaceutical compounds |
| 02/03/2009 | US7485724 2,4-pyrimidinediamine compounds and their uses |
| 02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |
| 02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485638 Pyrimidine compounds |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485626 Biosynthesis of Dna ; cell proliferation; overlapping enzyme activation ; mixture of proteolytic enzyme and dipeptidyl peptidase inhibitors; autoimmune disease; antiinflammatory agents graft versus host diease |
| 02/03/2009 | US7485456 Drug screening for a molecule capable of binding to NIK (nuclear factor kappa B inducing kinase); DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, isoforms, analogs, fragments and derivatives; gene expression |
| 02/03/2009 | US7485314 Induction of antigen specific immunologic tolerance |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2361377C Novel mucosal delivery system |
| 02/03/2009 | CA2223567C Modified meningococcal polysaccharide conjugate vaccines |
| 02/03/2009 | CA2185565C Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/30/2009 | CA2595671A1 Method and system for producing medicinal alcohol as a prophylatic or remedy for cancer, hiv, aids and autoimmune diseases |
| 01/29/2009 | WO2009015166A1 Piperidine derivatives as modulators of chemokine receptor activity |
| 01/29/2009 | WO2009014745A1 Antibodies to cd200 and uses thereof in inhibiting immune responses |
| 01/29/2009 | WO2009014702A2 Cd74 for use in the treatment of cancer and liver toxicity |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |
| 01/29/2009 | WO2009013543A2 Targeted binging agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | WO2009012647A1 Preparation methods of quinazoline derivatives and their pharmaceutical uses |
| 01/29/2009 | WO2009012601A1 Antigen-adjuvant compositions and methods |
| 01/29/2009 | WO2009012600A1 Fusion proteins |
| 01/29/2009 | WO2009012589A1 Vaccines and methods for treatment or prevention of gram negative bacterial infection in a vertebrate subject |
| 01/29/2009 | WO2009012588A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | WO2008149177A3 Marine lipid compositions and uses thereof |
| 01/29/2009 | WO2008114089A3 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 01/29/2009 | US20090030066 Small molecules for the protection of pancreatic cells |
| 01/29/2009 | US20090030051 Inhibitors of IMPDH enzyme |
| 01/29/2009 | US20090030032 Bicyclic Compound, Production and Use Thereof |
| 01/29/2009 | US20090030029 Novel benzonaphthyridines |
| 01/29/2009 | US20090030012 Pyridine, Pyrimidine and Pyrazine Derivatives as Cxcr3 Receptor Modulators |
| 01/29/2009 | US20090030002 Heterocyclic compounds and their uses |
| 01/29/2009 | US20090029998 Thiazole Derivatives and Use Thereof |
| 01/29/2009 | US20090029994 Trisubstituted amine compound |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029957 8-beta-substituted estratrienes as selectively active estrogens |
| 01/29/2009 | US20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 01/29/2009 | US20090029941 Methods for cell mobilization using in vivo treatment with hyaluronan (ha) |
| 01/29/2009 | US20090029906 Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
| 01/29/2009 | US20090029469 Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 01/29/2009 | US20090029459 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 01/29/2009 | US20090029361 Growth differentiation factor-7 |
| 01/29/2009 | US20090028970 Antiallergic composition |
| 01/29/2009 | US20090028945 Immunoisolative encapsulation system |
| 01/29/2009 | US20090028904 Novel cochleate formulations |
| 01/29/2009 | US20090028903 Novel use |
| 01/29/2009 | US20090028893 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 01/29/2009 | US20090028888 Cancer Antigen Mage-A9 and Uses Thereof |
| 01/29/2009 | US20090028887 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028875 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 01/29/2009 | US20090028872 Human monoclonal antibodies to cd70 |
| 01/29/2009 | US20090028871 Novel use of ligands specific to fex-2 polypeptide |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028843 IgA allelic variants |
| 01/29/2009 | US20090028835 Human transcriptome corresponding to human oocytes and use of said genes or the corresponding polypeptides to trans-differentiate somatic cells |
| 01/29/2009 | US20090028833 Proliferative Primary Human Sertoli Cell Cultures And Their Applications |
| 01/29/2009 | US20090028818 Heterocyclic antiviral compounds |
| 01/29/2009 | US20090028784 Antibodies to IL-6 and use thereof |
| 01/29/2009 | CA2720628A1 Fusion proteins |
| 01/29/2009 | CA2697159A1 Antibodies to cd200 and uses thereof in inhibiting immune responses |
| 01/29/2009 | CA2694466A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | CA2694083A1 Antigen-adjuvant compositions and methods |
| 01/28/2009 | EP2019098A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 01/28/2009 | EP2018872A1 Pharmaceutical product |
| 01/28/2009 | EP2018869A1 Licorice polyphenol preparation |
| 01/28/2009 | EP2018855A1 Pharmaceutical agent |
| 01/28/2009 | EP2018182A1 Immunogenic compositions |
| 01/28/2009 | EP1541672B1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/28/2009 | EP1015035B1 Vaccination by topical application of genetic vectors |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356262A Method for the preparation of anallergic probiotic bacterial cultures and related use |
| 01/28/2009 | CN101355970A Peptide-DICER substrate RNA conjugates as delivery vehicles for SIRNA |
| 01/28/2009 | CN101355967A Treating inflammatory disorders with antibodies to the alpha-7 |
| 01/28/2009 | CN101355957A Methods for fusion polypeptide delivery into a cell |